Patent caveat

Last updated

A patent caveat, often shortened to caveat, was a legal document filed with the United States Patent Office. [1]

Contents

History

Caveats were instituted by the U.S. Patent Act of 1836, but were discontinued in 1909, with the U.S. Congress abolishing the system formally in 1910. [2] A caveat was similar to a patent application with a description of an invention and drawings, but without examination for patentable subject matter and without a requirement for patent claims. A patent caveat was an official notice of intention to file a patent application at a later date. A caveat expired after one year, but could be renewed by paying an annual fee of $10. [2] [3]

Caveats were similar to provisional applications used today in the United States Patent and Trademark Office (USPTO) which also expire after one year. However, provisional applications today are non-renewable under any circumstances.

According to the Guide to the Practice of the Patent Office 1853, [4] the primary objective of a caveat was to prevent the issuing of a rival patent for the same invention to a subsequent inventor. Before the issuing of a patent, the caveats filed within the preceding year were searched. If one was found for the same invention as the proposed patent, the Patent Office notified the holder of the caveat, who then had three months to submit a formal patent application with claims. If the two patent applications claimed the same invention, an interference would then be declared and neither patent could be issued until it was determined which was the first to invent. [2]

Cost

The filing fee of $10 for a caveat was less costly than the filing fee $15 for a full patent application. [3] As stated by the USPTO: "In 1861, the fee for obtaining a full patent was $35, of which $15 was to be paid at the time of application and $20 when the patent was granted. In 1922, the patent filing fee increased from $15 to $20." However the patent caveat fee remained $10 per year until the caveat system was abolished. [3]

See also

Notes

  1. Patent Act of 1836
  2. 1 2 3 Thomas Edison Papers: American Patent System, Rutgers University, March 31, 2010.
  3. 1 2 3 U.S. Patent and Trademark Office. "The Story of the U.S. Patent and Trademark Office". Washington, D.C., Government Printing Office. Washington:IA-SuDocs, Rev. August 1988. iv, 50p. MC 89-8590. OCLC 19213162. SL 89-95-P. S/N 003-004-00640-4. $1.75. C 21.2:P 27/3/988 | Note: the 1861 filing fees are listed on Pg. 11, and the 1922 filing fees are listed on Pg. 22.
  4. Evenson, A.E. The Telephone Patent Conspiracy of 1876, p.66.

Related Research Articles

<span class="mw-page-title-main">United States Patent and Trademark Office</span> United States national patent bureau

The United States Patent and Trademark Office (USPTO) is an agency in the U.S. Department of Commerce that serves as the national patent office and trademark registration authority for the United States. The USPTO's headquarters are in Alexandria, Virginia, after a 2005 move from the Crystal City area of neighboring Arlington, Virginia.

The OncoMouse or Harvard mouse is a type of laboratory mouse that has been genetically modified using modifications designed by Philip Leder and Timothy A Stewart of Harvard University to carry a specific gene called an activated oncogene. The activated oncogene significantly increases the mouse's susceptibility to cancer, and thus makes the mouse a suitable model for cancer research.

Within the context of a national or multilateral body of law, an invention is patentable if it meets the relevant legal conditions to be granted a patent. By extension, patentability also refers to the substantive conditions that must be met for a patent to be held valid.

Under United States patent law, a continuing patent application is a patent application that follows, and claims priority to, an earlier-filed patent application. A continuing patent application may be one of three types: a continuation, divisional, or continuation-in-part. Although continuation and continuation-in-part applications are generally available in the U.S. only, divisional patent applications are also available in other countries, as such availability is required under Article 4G of the Paris Convention.

<span class="mw-page-title-main">Design patent</span> US Patent Law

In the United States, a design patent is a form of legal protection granted to the ornamental design of an article of manufacture. Design patents are a type of industrial design right. Ornamental designs of jewelry, furniture, beverage containers and computer icons are examples of objects that are covered by design patents.

In most patent laws, unity of invention is a formal administrative requirement that must be met for a patent application to proceed to grant. An issued patent can claim only one invention or a group of closely related inventions. The purpose of this requirement is administrative as well as financial. The requirement serves to preclude the possibility of filing one patent application for several inventions, while paying only one set of fees. Unity of invention also makes the classification of patent documents easier.

Under United States patent law, the term of patent, provided that maintenance fees are paid on time, is 20 years from the filing date of the earliest U.S. or international application to which priority is claimed.

A provisional application is a patent application filed at the intellectual property offices of some countries. It does not mature into an issued patent and is deemed abandoned one year after its filing. It is used to secure a filing date for a subsequent non-provisional patent application claiming priority of the provisional application. There is no such thing as a "provisional patent". The same term is used in past and current patent laws of different countries with different meanings.

Under United States law, a patent is a right granted to the inventor of a (1) process, machine, article of manufacture, or composition of matter, (2) that is new, useful, and non-obvious. A patent is the right to exclude others, for a limited time from profiting from a patented technology without the consent of the patent holder. Specifically, it is the right to exclude others from: making, using, selling, offering for sale, importing, inducing others to infringe, applying for an FDA approval, and/or offering a product specially adapted for practice of the patent.

Maintenance fees or renewal fees are fees paid to maintain a granted patent in force. Some patent laws require the payment of maintenance fees for pending patent applications. Not all patent laws require the payment of maintenance fees and different laws provide different regulations concerning not only the amount payable but also the regularity of the payments. In countries where maintenance fees are to be paid annually, they are sometimes called patent annuities.

A patent application is a request pending at a patent office for the grant of a patent for an invention described in the patent specification and a set of one or more claims stated in a formal document, including necessary official forms and related correspondence. It is the combination of the document and its processing within the administrative and legal framework of the patent office.

This is a list of legal terms relating to patents and patent law. A patent is not a right to practice or use the invention claimed therein, but a territorial right to exclude others from commercially exploiting the invention, granted to an inventor or their successor in rights in exchange to a public disclosure of the invention.

In former United States patent law, a statutory invention registration (SIR) was a publication of an invention by the United States Patent and Trademark Office (USPTO). The publication was made at the request of the applicant. In order for an applicant to have a patent application published as an SIR, the following conditions had to be met:

  1. The application must disclose the invention in sufficient detail that another person of ordinary skill in the art can make and use the invention without undue experimentation ;
  2. The application complies with the requirements for printing, as set forth in regulations of the Director of the patent office;
  3. The applicant waives the right to receive a patent on the invention within such period as may be prescribed by the Director; and
  4. The applicant pays application, publication, and other processing fees established by the Director.

Title 35 of the United States Code is a title of United States Code regarding patent law. The sections of Title 35 govern all aspects of patent law in the United States. There are currently 37 chapters, which include 376 sections, in Title 35.

A tax patent is a patent that discloses and claims a system or method for reducing or deferring taxes. Tax patents have been granted predominantly in the United States but can be granted in other countries as well. They are considered to be a form of business method patent. They are also called "tax planning patents", "tax strategy patents", and "tax shelter patents". In September 2011, President Barack Obama signed the Leahy-Smith America Invents Act passed by the U.S. Congress that effectively prohibits the granting of tax patents in general.

The history of United States patent law started even before the U.S. Constitution was adopted, with some state-specific patent laws. The history spans over more than three centuries.

<span class="mw-page-title-main">Patent drawing</span> Drawings illustrating patents

A patent application or patent may contain drawings, also called patent drawings, illustrating the invention, some of its embodiments, or the prior art. The drawings may be required by the law to be in a particular form, and the requirements may vary depending on the jurisdiction.

<span class="mw-page-title-main">Backlog of unexamined patent applications</span>

Although not clearly defined, the backlog of unexamined patent applications consists, at one point in time, of all the patent applications that have been filed and still remain to be examined. The backlog was said to be 4.2 million worldwide in 2007, and in 2009 it reportedly continued to grow. The United States Patent and Trademark Office (USPTO) alone had a backlog of ca. 700,000 patent applications in 2009. By May 22, 2024 this number grew to 783,134 applications.

<span class="mw-page-title-main">Leahy–Smith America Invents Act</span>

The Leahy–Smith America Invents Act (AIA) is a United States federal statute that was passed by Congress and signed into law by President Barack Obama on September 16, 2011. The law represents the most significant legislative change to the U.S. patent system since the Patent Act of 1952 and closely resembles previously proposed legislation in the Senate in its previous session.

<span class="mw-page-title-main">Outline of patents</span> Overview of and topical guide to patents

The following outline is provided as an overview of and topical guide to patents:

References

Further reading